Surgery Partners, Inc. (SGRY) — Financial statements
Income statement, balance sheet, and cash flow for Surgery Partners, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 3,309↑6.2% | 3,114↑13.5% | 2,743↑8.0% | 2,539↑14.1% | 2,225 | |
| Cost of Revenue | 2,544↑7.4% | 2,369↑13.0% | 2,096↑6.7% | 1,964↑13.3% | 1,734 | |
| Gross Profit | 765↑2.6% | 746↑15.2% | 648↑12.6% | 575↑17.0% | 491 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 523↑276.9% | 139↑14.7% | 121↑18.3% | 102↓1.7% | 104 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 523↑276.9% | 139↑14.7% | 121↑18.3% | 102↓1.7% | 104 | |
| Other Expenses | -147↓157.0% | 258↑30.0% | 199↑55.8% | 128↑49.6% | 85 | |
| Operating Expenses | 376↓5.4% | 397↑24.2% | 320↑39.1% | 230↑21.4% | 189 | |
| Total Costs & Expenses | 2,919↑5.6% | 2,766↑14.5% | 2,415↑10.1% | 2,194↑14.1% | 1,923 | |
| Operating Results | ||||||
| Operating Income | 390↑11.7% | 349↑6.3% | 328↓5.0% | 345↑14.2% | 302 | |
| Depreciation & Amortization | 176↑15.3% | 153↑29.2% | 118↑2.9% | 115↑16.2% | 99 | |
| EBITDA | 566↑12.8% | 501↑12.4% | 446↓3.0% | 460↑14.7% | 401 | |
| EBIT | 390↑11.7% | 349↑6.3% | 328↓5.0% | 345↑14.2% | 302 | |
| Interest & Other Income | ||||||
| Net Interest Income | -273↓35.2% | -202↓4.5% | -193↑17.8% | -235↓6.3% | -221 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 273↑35.2% | 202↑4.5% | 193↓17.8% | 235↑6.3% | 221 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | -273↓35.2% | -202↓4.5% | -193↑17.8% | -235↓6.3% | -221 | |
| Income Before Tax | 117↓20.5% | 147↑9.0% | 135↑22.4% | 110↑35.8% | 81 | |
| Income Tax Expense | 18↓86.6% | 135↑44966.7% | -0.30↓101.3% | 23↑121.9% | 11 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 99↑691.2% | 13↓90.8% | 135↑55.5% | 87↑23.1% | 71 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -78↑53.7% | -168↓1312.6% | -12↑78.2% | -55↑23.0% | -71 | |
| Bottom-Line Net Income | -78↑53.7% | -168↓1312.6% | -12↑78.2% | -55↑32.8% | -81 | |
| EPS (Basic) | -0.61↑54.1% | -1.33↓1304.4% | -0.09↑83.9% | -0.59↑47.3% | -1.12 | |
| EPS (Diluted) | -0.61↑54.1% | -1.33↓1304.4% | -0.09↑83.9% | -0.59↑47.3% | -1.12 | |
| Weighted Average Shares | 127↑0.9% | 126↑0.4% | 126↑36.6% | 92↑27.0% | 72 | |
| Weighted Average Diluted Shares | 127↑0.9% | 126↑0.4% | 126↑36.6% | 92↑27.0% | 72 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.